DeAngelis RA - Search Results

1

Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria.

Risitano AM, Ricklin D, Huang Y, Reis ES, Chen H, Ricci P, Lin Z, Pascariello C, Raia M, Sica M, Del Vecchio L, Pane F, Lupu F, Notaro R, Resuello RR, DeAngelis RA, Lambris JD. Risitano AM, et al. Among authors: deangelis ra. Blood. 2014 Mar 27;123(13):2094-101. doi: 10.1182/blood-2013-11-536573. Epub 2014 Feb 4. Blood. 2014. PMID: 24497537 Free PMC article.

2

New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties.

Qu H, Ricklin D, Bai H, Chen H, Reis ES, Maciejewski M, Tzekou A, DeAngelis RA, Resuello RR, Lupu F, Barlow PN, Lambris JD. Qu H, et al. Among authors: deangelis ra. Immunobiology. 2013 Apr;218(4):496-505. doi: 10.1016/j.imbio.2012.06.003. Epub 2012 Jun 17. Immunobiology. 2013. PMID: 22795972 Free PMC article.

3

Inhibition of biomaterial-induced complement activation attenuates the inflammatory host response to implantation.

Kourtzelis I, Rafail S, DeAngelis RA, Foukas PG, Ricklin D, Lambris JD. Kourtzelis I, et al. Among authors: deangelis ra. FASEB J. 2013 Jul;27(7):2768-76. doi: 10.1096/fj.12-225888. Epub 2013 Apr 4. FASEB J. 2013. PMID: 23558338 Free PMC article.

4

Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis.

Maekawa T, Abe T, Hajishengallis E, Hosur KB, DeAngelis RA, Ricklin D, Lambris JD, Hajishengallis G. Maekawa T, et al. Among authors: deangelis ra. J Immunol. 2014 Jun 15;192(12):6020-7. doi: 10.4049/jimmunol.1400569. Epub 2014 May 7. J Immunol. 2014. PMID: 24808362 Free PMC article.

5

Therapeutic C3 inhibitor Cp40 abrogates complement activation induced by modern hemodialysis filters.

Reis ES, DeAngelis RA, Chen H, Resuello RR, Ricklin D, Lambris JD. Reis ES, et al. Among authors: deangelis ra. Immunobiology. 2015 Apr;220(4):476-82. doi: 10.1016/j.imbio.2014.10.026. Epub 2014 Nov 3. Immunobiology. 2015. PMID: 25468722 Free PMC article.

6

Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis.

DeAngelis RA, Reis ES, Ricklin D, Lambris JD. DeAngelis RA, et al. Immunobiology. 2012 Nov;217(11):1097-105. doi: 10.1016/j.imbio.2012.07.012. Immunobiology. 2012. PMID: 22964235 Free PMC article. Review.

7

Complexity of complement activation in sepsis.

Markiewski MM, DeAngelis RA, Lambris JD. Markiewski MM, et al. Among authors: deangelis ra. J Cell Mol Med. 2008 Dec;12(6A):2245-54. doi: 10.1111/j.1582-4934.2008.00504.x. J Cell Mol Med. 2008. PMID: 18798865 Free PMC article. Review.

8

Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis.

Langer HF, Chung KJ, Orlova VV, Choi EY, Kaul S, Kruhlak MJ, Alatsatianos M, DeAngelis RA, Roche PA, Magotti P, Li X, Economopoulou M, Rafail S, Lambris JD, Chavakis T. Langer HF, et al. Among authors: deangelis ra. Blood. 2010 Nov 25;116(22):4395-403. doi: 10.1182/blood-2010-01-261503. Epub 2010 Jul 12. Blood. 2010. PMID: 20625009 Free PMC article.

9

[No title available]

[No authors listed] [No authors listed] PMID: 23402036

10

Induction of complement C3a receptor responses by kallikrein-related peptidase 14.

Oikonomopoulou K, DeAngelis RA, Chen H, Diamandis EP, Hollenberg MD, Ricklin D, Lambris JD. Oikonomopoulou K, et al. Among authors: deangelis ra. J Immunol. 2013 Oct 1;191(7):3858-66. doi: 10.4049/jimmunol.1202999. Epub 2013 Sep 6. J Immunol. 2013. PMID: 24014879 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page